Barrington Research Expects Lower Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Barrington Research decreased their Q1 2025 EPS estimates for Henry Schein in a research note issued on Wednesday, February 26th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $1.04 per share for the quarter, down from their previous forecast of $1.06. Barrington Research has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.16 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.84 EPS, Q1 2026 earnings at $1.13 EPS, Q2 2026 earnings at $1.28 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.43 EPS, FY2026 earnings at $5.22 EPS and FY2027 earnings at $5.65 EPS.

Several other equities analysts also recently commented on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday. Jefferies Financial Group boosted their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Trading Down 4.3 %

HSIC stock opened at $72.54 on Thursday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.63. The business has a 50 day simple moving average of $74.28 and a two-hundred day simple moving average of $72.43. The company has a market capitalization of $9.04 billion, a price-to-earnings ratio of 29.85, a PEG ratio of 2.13 and a beta of 0.91.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 EPS.

Hedge Funds Weigh In On Henry Schein

Several large investors have recently modified their holdings of HSIC. Invesco Ltd. boosted its stake in Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock worth $343,468,000 after buying an additional 17,552 shares during the period. FMR LLC lifted its holdings in shares of Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company’s stock worth $242,064,000 after acquiring an additional 217,143 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Henry Schein by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after purchasing an additional 14,876 shares during the period. Palestra Capital Management LLC bought a new position in Henry Schein during the 4th quarter valued at about $182,988,000. Finally, Southpoint Capital Advisors LP raised its position in Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.